반응식
[Na].[CH2:2]([N:8]1[C:17](=[O:18])[C:16]2[NH:15][CH:14]=[N:13][C:12]=2[N:11]([CH3:19])[C:9]1=[O:10])[CH2:3][CH2:4][CH2:5][CH2:6][CH3:7].Cl[CH2:21][P:22](=[O:25])([CH3:24])[CH3:23]>>[CH2:2]([N:8]1[C:17](=[O:18])[C:16]2[N:15]([CH2:21][P:22](=[O:25])([CH3:24])[CH3:23])[CH:14]=[N:13][C:12]=2[N:11]([CH3:19])[C:9]1=[O:10])[CH2:3][CH2:4][CH2:5][CH2:6][CH3:7]참가 물질
3
실험 절차
The title substance was prepared from 26 g (0.1 mol) of 1-hexyl-3-methylxanthine sodium salt and chloromethyldimethylphosphine oxide analogously to Example 59 and crystallized from hexane.
후처리
- customcrystallized from hexane
출처 및 근거
- ORD 기록
- ord-ef1db8c6e55e47b682289c4e57d4ed22
- 출처 데이터셋
- uspto-grants-1998_03
- 특허 번호
- US05728686
연결된 노트
불러오는 중…